Xiaoding Xu
Harvard University
H-index: 48
North America-United States
Top articles of Xiaoding Xu
Redox‐Responsive Polymeric Nanoparticle for Nucleic Acid Delivery and Cancer Therapy: Progress, Opportunities, and Challenges
2024/3
Remodeling of Mitochondrial Metabolism by a Mitochondria‐Targeted RNAi Nanoplatform for Effective Cancer Therapy
Small
2024/3
Nanomedicine targeting ferroptosis to overcome anticancer therapeutic resistance
2024/1
Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy
Acta Pharmaceutica Sinica B
2023/12/1
LARAI portal provides a safe method for lateral meniscus repair: three-dimensional computed tomography and cadaveric assessment
Journal of Orthopaedics and Traumatology
2023/9/29
The critical shoulder angle can be accurately and reliably determined from three‐dimensional computed tomography images
Orthopaedic Surgery
2023/8
Nanoparticles (NPs)-mediated lncBCMA silencing to promote eEF1A1 ubiquitination and suppress breast cancer growth and metastasis
Acta Pharmaceutica Sinica B
2023/8/1
Role of long non-coding RNAs (lncRNAs) in cancer: from subcellular localization to nanoparticles (NPs)-mediated targeted regulation
2023/7/16
Remodeling Serine Synthesis and Metabolism via Nanoparticles (NPs)‐Mediated CFL1 Silencing to Enhance the Sensitivity of Hepatocellular Carcinoma to Sorafenib
Advanced Science
2023/7
Lei Xu
H-Index: 3
Guo Wu
H-Index: 5
Qian Shen
H-Index: 4
Rong Li
H-Index: 7
Lei Zhang
H-Index: 20
Xiaoding Xu
H-Index: 28
Repolarization of macrophages to improve sorafenib sensitivity for combination cancer therapy
Acta Biomaterialia
2023/5/1
Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling
Journal of Experimental & Clinical Cancer Research
2023/3/11
Zixian Huang
H-Index: 2
Rui Chen
H-Index: 7
Yan Wang
H-Index: 2
Xiaoding Xu
H-Index: 28
Zhiquan Huang
H-Index: 16
Nanoparticles (NPs)-mediated systemic mRNA delivery to reverse trastuzumab resistance for effective breast cancer therapy
Acta Pharmaceutica Sinica B
2023/3/1
Ying Wang
H-Index: 3
Xiaoding Xu
H-Index: 28
Supramolecular peptide hydrogel doped with nanoparticles for local siRNA delivery and diabetic wound healing
Chemical Engineering Journal
2023/2/1
Yanbo Chen
H-Index: 13
Gang Zeng
H-Index: 19
Na Mao
H-Index: 3
Na Li
H-Index: 5
Xiaoding Xu
H-Index: 28
Li Yan
H-Index: 4
Bioactive lipid-nanoparticles with inherent self-therapeutic and anti-angiogenic properties for cancer therapy
Acta Biomaterialia
2023/2/1
Corrigendum to" Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy"[Biomater. 234 (2020) 119760]
Biomaterials
2023/2
Phei Er Saw
H-Index: 25
Yan Nie
H-Index: 11
Wei Tao
H-Index: 45
Lei Zhang
H-Index: 20
Xiaoding Xu
H-Index: 28
HPV enhances HNSCC chemosensitization by inhibiting SERPINB3 expression to disrupt the fanconi anemia pathway
Advanced Science
2023/1
Stimuli-responsive polyprodrug for cancer therapy
Materials Today Advances
2022/8/1
Phei Er Saw
H-Index: 25
Xiaoding Xu
H-Index: 28
Stimuli-responsive nanoparticles for biomedical applications
2022/7/21
Nanoparticles‐Mediated CRISPR/Cas Gene Editing Delivery System
2022/5/4
Phei Er Saw
H-Index: 25
Xiaoding Xu
H-Index: 28
LncRNA Uc003xsl. 1-Mediated activation of the NFκB/IL8 axis promotes progression of triple-negative breast cancer
Cancer research
2022/2/15
